Onvoloxastat (INN; developmental code names CAD-1005, VLX-1005, and ML355) is a 12-lipoxygenase (12-LOX; ALOX12) inhibitor which is under development for the treatment of heparin-induced thrombocytopenia and thrombosis syndrome (HITTS), acute kidney injury, and diabetes.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.